Showing 3001-3020 of 7110 for: Cochrane Systematic Reviews Back
- Interactive telemedicine: effects on professional practice and health care outcomes
Cochrane Systematic Reviews, 31-Aug-2015
Telemedicine (TM) is the use of telecommunication systems to deliver health care at a distance. It has the potential to improve patient health outcomes, access to health care and reduce healthcare costs. As TM applications continue to evolve it is importa
- Intercessory prayer for the alleviation of ill health
Cochrane Systematic Reviews, 4-Jun-2014
Prayer is amongst the oldest and most widespread interventions used with the intention of alleviating illness and promoting good health. Given the significance of this response to illness for a large proportion of the world's population, there has been co
- Interconception care for women with a history of gestational diabetes for improving maternal and infant outcomes
Cochrane Systematic Reviews, 31-May-2013
Gestational diabetes mellitus (GDM) is associated with adverse health outcomes for both mother and infant both perinatally and long-term. Women with a history of GDM are at risk of recurrence in subsequent pregnancies and may benefit from intervention in
- Interdental brushing for the prevention and control of periodontal diseases and dental caries in adults
Cochrane Systematic Reviews, 16-Dec-2013
Effective oral hygiene is a crucial factor in maintaining good oral health, which is associated with overall health and health-related quality of life. Dental floss has been used for many years in conjunction with toothbrushing for removing dental plaque
- Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer
Cochrane Systematic Reviews, 1-Apr-2015
Epithelial ovarian cancer (EOC) is a life-threatening disease. Most often women become symptomatic only in the advanced stages of the disease, increasing the difficulty of treatment. Whilst the disease responds well to surgery and chemotherapy, the relaps
- Interferon alpha for chronic hepatitis D
Cochrane Systematic Reviews, 1-Nov-2011
Hepatitis D virus is a small defective RNA virus that requires the presence of hepatitis B virus infection to infect a person. Hepatitis D is a difficult-to-treat infection. Several clinical trials have been published on the efficacy of interferon alpha f
- Interferon alpha for the adjuvant treatment of cutaneous melanoma
Cochrane Systematic Reviews, 12-Oct-2015
Interferon alpha is the only agent approved for the postoperative adjuvant treatment of high-risk cutaneous melanoma. However, the survival advantage associated with this treatment is unclear, especially in terms of overall survival. Thus, adjuvant interf
- Interferon Beta for Primary Progressive Multiple Sclerosis
Cochrane Systematic Reviews, 2-Nov-2009
This is an updated Cochrane review of the previous version published (Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006643. DOI: 10.1002/14651858.CD006643.pub2).
- Interferon beta for secondary progressive multiple sclerosis
Cochrane Systematic Reviews, 29-Nov-2011
Therapy with either recombinant beta-1a or beta-1b interferons (IFNs) is worldwide approved for Relapsing Remitting Multiple Sclerosis (RRMS). A major unanswered question is whether this treatment is able to safely reverse or retard the progressive phase
- Interferon for acute hepatitis C
Cochrane Systematic Reviews, 8-Nov-2008
Acute hepatitis C virus (HCV) infection progresses to chronicity in the majority of patients. In order to prevent the progression to chronic disease, several studies have assessed interferon in patients with acute hepatitis C.
- Interferon for interferon naive patients with chronic hepatitis C
Cochrane Systematic Reviews, 8-Nov-2008
A previous meta-analysis of interferon therapy in naive patients with chronic hepatitis C has documented its efficacy in achieving virologic clearance, and improving liver biochemistry and histology; however, since its publication additional trials have b
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C
Cochrane Systematic Reviews, 14-Dec-2012
The widely-accepted treatment outcome for chronic hepatitis C is the sustained viral response (that is, no measurable viral RNA in blood six months after treatment). However, this surrogate outcome (as well as the previously employed biochemical and histo
- Interferon in relapsing-remitting multiple sclerosis
Cochrane Systematic Reviews, 17-Sep-2008
Recombinant interferons have been shown to suppress both the clinical and magnetic resonance imaging (MRI) measures of disease activity in patients with relapsing remitting multiple sclerosis (RRMS).
- Interferon-alpha for maintenance of follicular lymphoma
Cochrane Systematic Reviews, 10-Nov-2009
Indolent non-Hodgkin's lymphoma, in particular follicular lymphoma (FL), is characterized by multiple remissions and relapses. Several studies have used interferon-alpha (IFN) to control this disease, both as induction and as maintenance therapy. It is no
- Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis
Cochrane Systematic Reviews, 22-Jul-2014
Interferons (IFNs)-beta and glatiramer acetate (GA) were the first two disease-modifying therapies (DMTs) approved 15 years ago for the treatment of multiple sclerosis (MS). DMTs prescription rates as first or switching therapies and their costs have incr
- Interleukin 2 receptor antagonists for kidney transplant recipients
Cochrane Systematic Reviews, 2-May-2014
Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, but the proportion of new transplant recipients
- Interleukin-1 inhibitors for acute gout
Cochrane Systematic Reviews, 27-Aug-2014
Acute gout flares cause significant pain and disability and it is important to provide quick and effective pain relief. Traditional options for managing acute flares include colchicine, non-steroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids.
- Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission
Cochrane Systematic Reviews, 3-Nov-2015
Acute myeloid leukaemia (AML) is a malignant cancer of hematopoietic stem cells. The treatment of AML consists of two treatment phases: the remission induction phase to achieve a rapid, complete remission (CR) and the consolidation phase to achieve a dura
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus
Cochrane Systematic Reviews, 13-May-2008
Diabetes mellitus type 1 is a chronic disease with short and long term complications. Its goals of therapy are to eliminate the symptoms of hyperglycaemia, reduce the long term microvascular and macrovascular complications and allow the patients to achiev
- Intermittent catheter techniques, strategies and designs for managing long‐term bladder conditions
Cochrane Systematic Reviews, 26-Oct-2021
Intermittent catheterisation (IC) is a commonly recommended procedure for people with incomplete bladder emptying. Frequent complications are urinary tract infection (UTI), urethral trauma and discomfort during catheter use. Despite the many designs of in
